Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder

被引：0
|
作者：
Sheng-lin Wen
Mu-hua Cheng
Min-feng Cheng
Ji-hui Yue
Hong Wang
机构：
[1] Sun Yat-sen University,Department of Psychiatry, Third Affiliated Hospital
[2] Sun Yat-sen University,Department of Nuclear Medicine, Third Affiliated Hospital
[3] Sun Yat-sen University,Department of Psychology, Fifth Affiliated Hospital
来源：
Behavioral and Brain Functions | / 9卷
关键词：
Obsessive-compulsive disorder; Regional cerebral blood flow; SSRI; Quetiapine; Therapy response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder. A SPECT study.
    Benedicto Crespo-Facorro
    Jose A. Cabranes
    Maria I. López-Ibor Alcocer
    Beatriz Payá
    Cristina Fernández Pérez
    Marta Encinas
    Jose L. Ayuso Mateos
    Juan J. López-Ibor Jr
    European Archives of Psychiatry and Clinical Neuroscience, 1999, 249 : 156 - 161
  • [32] Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder.: A SPECT study.
    Crespo-Facorro, B
    Cabranes, JA
    Alcocer, MILI
    Payá, B
    Pérez, CF
    Encinas, M
    Mateos, JLA
    Lopez-Ibor, JJ
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (03) : 156 - 161
  • [33] Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder
    Landeros-Weisenberger, Angeli
    Bloch, Michael H.
    Kelmendi, Ben
    Wegner, Ryan
    Nudel, Jake
    Dombrowski, Philip
    Pittenger, Christopher
    Krystal, John H.
    Goodman, Wayne K.
    Leckman, James F.
    Coric, Vladimir
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 121 (1-2) : 175 - 179
  • [34] REGIONAL CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDERED PATIENTS AT REST - DIFFERENTIAL CORRELATES WITH OBSESSIVE-COMPULSIVE AND ANXIOUS-AVOIDANT DIMENSIONS
    LUCEY, JV
    COSTA, DC
    BLANES, T
    BUSATTO, GF
    PILOWSKY, LS
    TAKEI, N
    MARKS, IM
    ELL, PJ
    KERWIN, RW
    BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 : 629 - 634
  • [35] Cerebral glucose metabolism change after pharmacotherapy in obsessive-compulsive disorder
    Kang, DH
    Youn, T
    Lee, DS
    Lee, MC
    Lee, JS
    Kim, JJ
    Kwon, JS
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S90 - S90
  • [36] PHARMACOTHERAPY OF OBSESSIVE-COMPULSIVE DISORDER - EXPERIENCE WITH FLUOXETINE
    WOOD, A
    TOLLEFSON, GD
    BIRKETT, M
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 (04) : 301 - 306
  • [37] On the pharmacotherapy of obsessive-compulsive disorder: Is a consensus possible?
    Todorov, C
    Freeston, MH
    Borgeat, F
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (03): : 257 - 262
  • [38] Longitudinal course of pharmacotherapy in obsessive-compulsive disorder
    Grant, Jon E.
    Mancebo, Maria C.
    Weinhandl, Eric
    Odlaug, Brian L.
    Eisen, Jane L.
    Rasmussen, Steven A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) : 200 - 205
  • [39] Assessing the effectiveness of pharmacotherapy for obsessive-compulsive disorder
    Johnson, Jeremy C. S.
    Scott, James G.
    Jess, Naomi
    LANCET PSYCHIATRY, 2016, 3 (11): : E16 - E16
  • [40] METAANALYSIS OF PHARMACOTHERAPY TRIALS FOR OBSESSIVE-COMPULSIVE DISORDER
    STEIN, DJ
    SPADACCINI, E
    HOLLANDER, E
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (01) : 11 - 18
12345